TWST
Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH
$85.47
-3.48% today
Updated 2026-07-29
Market cap
$5.84B
P/E ratio
—
P/S ratio
14.27x
EPS (TTM)
$-1.32
Dividend yield
—
52W range
$23 – $105
Volume
1.8M
Twist Bioscience Corp (TWST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$85.47
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$117.77
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.2B | $0.3B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -19.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.